Purchase Order 75N92B20P00042
Award Date 8/4/20
Potential Completion Date 8/4/20
Potential Value $20K
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98102, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for $29,900.00 on September 12, 2019, for ImmunoSEQ HSTCRB V4 assay services. Performance of work is located in Bethesda, Maryland, with a completion date of February 28, 2020. The purchase order was issued without a set-aside designation under a pre-solicitation opportunity posted July 24, 2019.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for immunosequencing services (ImmunoSEQ MMTCRB sequencing) valued at $12,200.00, with award and completion dates of July 12, 2018 and July 12, 2019 respectively.</p> <p>Performance occurs in Seattle, Washington. The order is firm fixed price with no set-aside designation.</p>
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for $11,475 on November 2, 2020, for immunosequencing extraction services. Work is performed in Seattle, Washington. The order carries a firm fixed-price structure with an ultimate completion date of December 31, 2020. This award was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation valued at $16,800 on September 6, 2017, with an ultimate completion date of September 14, 2017. Place of performance is Seattle, Washington. The order is for firm fixed-price immunosequencing services. No set-aside category applies.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Adaptive Biotechnologies Corporation for $20,000 on July 11, 2019, with an ultimate completion date of July 11, 2020. Work is performed at Bethesda, Maryland. The order procures immunosequencing services under firm fixed-price commercial terms. No set-aside was used.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Adaptive Biotechnologies Corporation for $26,942 on July 25, 2019, for ImmunoSEQ Assay sequencing kits and reagents. This was a Total Small Business set-aside acquisition with firm fixed-price pricing. Place of performance is Seattle, Washington. The order was issued under a Total Small Business solicitation posted July 18, 2019, and carries an ultimate completion date of August 24, 2019.</p>
- <p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $308,400 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, to provide COVID-19 funded immunoseq sequencing services for a COVID-19 research project. The contract will be performed in Seattle, Washington and has a period of performance from November 10, 2022 through May 10, 2023.</p>
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Adaptive Biotechnologies Corporation (also doing business as Adaptive) for IMMUNOSEQ MMTCRB SERVICE. The contract, valued at $12,200.00, does not have a set-aside designation. Through this award, Adaptive Biotechnologies will provide specialized sequencing and testing services to support HHS research programs. Adaptive...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Adaptive Biotechnologies Corporation for DNA extraction services (ImmunoSEQ) valued at $21,225.00 on September 15, 2021. Performance is located in Bethesda, Maryland. The order is priced on a firm fixed-price basis with no small business set-aside. The ultimate completion date is January 7, 2022. This purchase order supports the FY26 UDO Initiative DNA Extraction Services requirement and procures...
- This is a $12,300 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (Adaptive) for "IMMUNOSEQ MMTCRB SEQUENCING SERVICE". The contract has an ultimate completion date of December 31, 2023 and was awarded on September 19, 2023 without a set-aside designation. Adaptive, a for-profit organization, has previously...